162 related articles for article (PubMed ID: 31742804)
1. Exome sequencing identifies a FHOD3 p.S527del mutation in a Chinese family with hypertrophic cardiomyopathy.
Huang S; Pu T; Wei W; Xu R; Wu Y
J Gene Med; 2020 Mar; 22(3):e3146. PubMed ID: 31742804
[TBL] [Abstract][Full Text] [Related]
2. Variant Spectrum of Formin Homology 2 Domain-Containing 3 Gene in Chinese Patients With Hypertrophic Cardiomyopathy.
Wu G; Ruan J; Liu J; Zhang C; Kang L; Wang J; Zou Y; Song L
J Am Heart Assoc; 2021 Feb; 10(5):e018236. PubMed ID: 33586461
[TBL] [Abstract][Full Text] [Related]
3. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.
Ochoa JP; Sabater-Molina M; García-Pinilla JM; Mogensen J; Restrepo-Córdoba A; Palomino-Doza J; Villacorta E; Martinez-Moreno M; Ramos-Maqueda J; Zorio E; Peña-Peña ML; García-Granja PE; Rodríguez-Palomares JF; Cárdenas-Reyes IJ; de la Torre-Carpente MM; Bautista-Pavés A; Akhtar MM; Cicerchia MN; Bilbao-Quesada R; Mogollón-Jimenez MV; Salazar-Mendiguchía J; Mesa Latorre JM; Arnaez B; Olavarri-Miguel I; Fuentes-Cañamero ME; Lamounier A; Pérez Ruiz JM; Climent-Payá V; Pérez-Sanchez I; Trujillo-Quintero JP; Lopes LR; Repáraz-Andrade A; Marín-Iglesias R; Rodriguez-Vilela A; Sandín-Fuentes M; Garrote JA; Cortel-Fuster A; Lopez-Garrido M; Fontalba-Romero A; Ripoll-Vera T; Llano-Rivas I; Fernandez-Fernandez X; Isidoro-García M; Garcia-Giustiniani D; Barriales-Villa R; Ortiz-Genga M; García-Pavía P; Elliott PM; Gimeno JR; Monserrat L
J Am Coll Cardiol; 2018 Nov; 72(20):2457-2467. PubMed ID: 30442288
[TBL] [Abstract][Full Text] [Related]
4. Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathy.
Ochoa JP; Lopes LR; Perez-Barbeito M; Cazón-Varela L; de la Torre-Carpente MM; Sonicheva-Paterson N; De Uña-Iglesias D; Quinn E; Kuzmina-Krutetskaya S; Garrote JA; Elliott PM; Monserrat L
Clin Genet; 2020 Jul; 98(1):86-90. PubMed ID: 32335906
[TBL] [Abstract][Full Text] [Related]
5. Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.
Wooten EC; Hebl VB; Wolf MJ; Greytak SR; Orr NM; Draper I; Calvino JE; Kapur NK; Maron MS; Kullo IJ; Ommen SR; Bos JM; Ackerman MJ; Huggins GS
Circ Cardiovasc Genet; 2013 Feb; 6(1):10-8. PubMed ID: 23255317
[TBL] [Abstract][Full Text] [Related]
6. CSRP3, p.Arg122*, is responsible for hypertrophic cardiomyopathy in a Chinese family.
Huang H; Chen Y; Jin J; Du R; Tang K; Fan L; Xiang R
J Gene Med; 2022 Jan; 24(1):e3390. PubMed ID: 34558151
[TBL] [Abstract][Full Text] [Related]
7. A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans-A cohort study.
Vodnjov N; Toplišek J; Maver A; Čuturilo G; Jaklič H; Teran N; Višnjar T; Škrjanec Pušenjak M; Hodžić A; Miljanović O; Peterlin B; Writzl K
PLoS One; 2023; 18(12):e0294969. PubMed ID: 38051749
[TBL] [Abstract][Full Text] [Related]
8. Whole-exome sequencing reveals a likely pathogenic LMNA variant causing hypertrophic cardiomyopathy.
Mahdavi M; Mohsen-Pour N; Maleki M; Ghasemi S; Tabib A; Houshmand G; Naderi N; Masoumi T; Pouraliakbar H; Kalayinia S
Lab Med; 2024 Jan; 55(1):62-70. PubMed ID: 37246508
[TBL] [Abstract][Full Text] [Related]
9. A novel nonsense mutation in TNNT2 in a Chinese pedigree with hypertrophic cardiomyopathy: A case report.
Gao G; Liu G; Chen W; Tong Y; Mao C; Liu J; Zhang X; He MM; Yang P
Medicine (Baltimore); 2020 Aug; 99(34):e21843. PubMed ID: 32846832
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing combined with integrated variant annotation prediction identifies a causative myosin essential light chain variant in hypertrophic cardiomyopathy.
Nomura A; Tada H; Teramoto R; Konno T; Hodatsu A; Won HH; Kathiresan S; Ino H; Fujino N; Yamagishi M; Hayashi K
J Cardiol; 2016 Feb; 67(2):133-9. PubMed ID: 26443374
[TBL] [Abstract][Full Text] [Related]
11. [P1208fs mutation in the cardiac myosin binding protein C is associated with hypertrophic cardiomyopathy in a Chinese pedigree].
Li J; Liu LW; Na LS; Zuo L; Qi W; Liu Y; Shao H; Ma ZL; Wang LF
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):321-6. PubMed ID: 27112610
[TBL] [Abstract][Full Text] [Related]
12. Intermediate-effect size p.Arg637Gln in
Piqueras-Flores J; Villacorta-Argüelles E; Galvin J; Climent-Payá V; Escobar-López LE; Amor-Salamanca A; Garcia-Hernandez S; Esmonde S; Martínez-Del Río J; Soto-Pérez M; Garcia-Pavia P; Ochoa JP
J Med Genet; 2024 Apr; 61(5):423-427. PubMed ID: 38160043
[TBL] [Abstract][Full Text] [Related]
13. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
[TBL] [Abstract][Full Text] [Related]
14. FLNC and MYLK2 Gene Mutations in a Chinese Family with Different Phenotypes of Cardiomyopathy.
Qin X; Li P; Qu HQ; Liu Y; Xia Y; Chen S; Yang Y; Huang S; Wen P; Zhou X; Li X; Wang Y; Tian L; Hakonarson H; Wu Y; Zhuang J
Int Heart J; 2021 Jan; 62(1):127-134. PubMed ID: 33455984
[TBL] [Abstract][Full Text] [Related]
15. A de novo mutation of SMYD1 (p.F272L) is responsible for hypertrophic cardiomyopathy in a Chinese patient.
Fan LL; Ding DB; Huang H; Chen YQ; Jin JY; Xia K; Xiang R
Clin Chem Lab Med; 2019 Mar; 57(4):532-539. PubMed ID: 30205637
[TBL] [Abstract][Full Text] [Related]
16. Potential digenic inheritance of familial hypertrophic cardiomyopathy identified by whole-exome sequencing.
Ren MB; Chai XR; Li L; Wang X; Yin C
Mol Genet Genomic Med; 2020 Mar; 8(3):e1150. PubMed ID: 31960626
[TBL] [Abstract][Full Text] [Related]
17. Whole-exome sequencing identifies rare compound heterozygous mutations in the MYBPC3 gene associated with severe familial hypertrophic cardiomyopathy.
Zhou N; Qin S; Liu Y; Tang L; Zhao W; Pan C; Qiu Z; Wang X; Shu X
Eur J Med Genet; 2018 Aug; 61(8):434-441. PubMed ID: 29524613
[TBL] [Abstract][Full Text] [Related]
18. A novel
Tong W; Liu W; Guo H; Wang J; Yu S; Zhang J; Liu C; Chen J; Zhao X
Cardiol Young; 2020 Jan; 30(1):100-106. PubMed ID: 31747981
[TBL] [Abstract][Full Text] [Related]
19. Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.
Bagnall RD; Ingles J; Dinger ME; Cowley MJ; Ross SB; Minoche AE; Lal S; Turner C; Colley A; Rajagopalan S; Berman Y; Ronan A; Fatkin D; Semsarian C
J Am Coll Cardiol; 2018 Jul; 72(4):419-429. PubMed ID: 30025578
[TBL] [Abstract][Full Text] [Related]
20. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
Maron BJ; Maron MS; Semsarian C
J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
